title: Optic neuropathy in patients with glioblastoma receiving bevacizumab.
authors.forename: Marc C
authors.initials: MC
authors.lastname: Chamberlain
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Raizer
authors.forename: David
authors.initials: D
authors.lastname: Schiff
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Sherman
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy*; D005909:Glioblastoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009901:Optic Nerve Diseases / Q000150:complications / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab